Oppenheimer Maintains Outperform on Amgen, Maintains $380 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Jay Olson maintains an Outperform rating on Amgen (NASDAQ:AMGN) with a $380 price target.
August 07, 2024 | 5:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Jay Olson maintains an Outperform rating on Amgen with a $380 price target.
The reaffirmation of an Outperform rating and a high price target by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100